Animalcare (LON:ANCR) Group (ANCR) [129p/£26.73 million]
One of the leading suppliers of veterinary medicines announced the launch of a new product for problems related to canine ageing. Vitofyllin will be available in tablet form and acts as a central nervous system stimulant for older dogs suffering from dullness, poor demeanour and unwillingness to exercise. This forms part of a collaboration between Animalcare and three of its European partners, and has enhanced the company's in-house expertise having been contract synthesised. The regulatory procedure was also the first time a bioequivalence bio-waiver had been successfully applied for and obtained in Europe. The market in the UK and Ireland is said to be worth £1.5 million per annum.
BlueStar SecuTech (BSST) [6p/£4.4 million]
BlueStar SecuTech, a supplier of digital video surveillance solutions in China, has announced that it has received an order from the Bank of Beijing, worth approximately ¥5 million (£0.5 million). The contract is for the provision of networked surveillance services and solutions for the second part of a project with Bank of Beijing. The company has also won a contract with Shanghai Pudong Development Bank. The order, worth approximately ¥1.7 million (£0.2 million), will help build a network command center in the Chengdu branch.
Craneware (LON:CRW) (CRW) [425p/£114.72 million]
The Edinburgh-headquartered provider of automated revenue integrity solutions for the US healthcare market announced final results for the year to 31 December 2012. Revenue was up 8% to $41.1 million (£25.5 million; 2011: $38.1 million) whilst adjusted pre-tax profit increased by 16% to $10.8 million (2011: $9.3 million). Cash at year end continued at a strong level of $28.8 million (2011: $24.2 million), and a dividend of 5.7p is to be paid taking the total dividend for the period to 10.5p, some 19% higher than the year before (2011: 8.8p).
The company's progress continues to be closely linked with the navigation of the US healthcare market, which is seeing healthcare facilities across the country looking for efficiency gains across their revenue generating areas. Whilst 75-80% of revenues currently come from the Annuity SAAS model, which sees licence fees invoiced over a five-year contract, the balance of revenues continue to come from professional services implementation and a pure SAAS model with monthly invoicing and revenue recognition, as the company seeks to phase these out one can expect to see continuing benefits…
